Vaccines 2016-2022: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)

    Published: March 25, 2016 | Price: $3,360.00 – $6,720.00

    Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others) Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types of disease. The report provides a comprehensive revenue summary, including revenue growth of vaccines vs. pharmaceuticals, 2013-2022; global market for vaccines by type, pediatric vs. adult, 2013-2022; global vaccines revenues by vaccine type, 2013-2022 (pediatric: combinations, hepatitis, HIB, MMR, pneumococcal,...
    Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

    Published: August 8, 2018 | Price: $4,500.00 – $9,000.00

    Vaccines 2018-2024: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others) Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments provides a complete global revenue summary, including the total global market for preventive vaccines by type for 2015 to 2024 (pediatric total: combinations, hepatitis, haemophilus influenzae type B, measles, mumps and rubella, pneumococcal, poliovirus, varicella, others; adult total: cervical, hepatitis, influenza, pneumococcal, travel and other;...
    Vaccines 2020: World Market Analysis, Players, Trends

    Published: November 4, 2020 | Price: $4,000.00 – $8,000.00

    Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION  The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...
    Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

    Published: April 1, 2008 | Price: $995.00 – $8,200.00

    Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected profits have transformed the vaccine marketplace. Approvals that have been granted for products such as RotaTeq, Pentacel, Adacel and Zostavax and FluMist are now impacting the market. The launch and execution of the first...
    Veterinary Diagnostics Markets

    Published: October 1, 2009 | Price: $995.00 – $1,990.00

    Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...
    Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities

    Published: December 20, 2021 | Price: $3,000.00 – $6,000.00

    Viral vectors are useful tools used by molecular biologists to delivery genetic material into cells. Kalorama Information’s Viral Vectors Market Analysis and Opportunities reveals that viral vectors comprise a rising market that is expected to continue to grow as usage increases and novel technologies enter the market. Viral vectors are the most effective means of gene transfer to modify specific cells or alter the expression of therapeutic genes. The choice of viral vector depends on the efficiency of transgene expression,...
    Virtual Reality (VR) in Healthcare in the U.S. (Markets for Surgery, Visualization, Rehabilitation and Training)

    Published: February 1, 2011 | Price: $150.00 – $300.00

    What are virtual reality technologies and how are they being used in healthcare today? What areas of healthcare are seeing the most use of these products? What is the expected market opportunity for companies entering the market for VR equipment? Who are the main players in the VR market and what moves are they making to grow market share? These are among the questions answered in Kalorama Information's Virtual Reality in Healthcare in the U.S. The use of virtual reality...
    Virtual Reality and Augmented Reality Market in Healthcare (U.S. Markets for Surgical VR; Medical Education and Training Applications for VR and AR; Pain Management, Rehabilitation)

    Published: May 11, 2017 | Price: $3,196.00 – $6,392.00

    Virtual Reality and Augmented Reality (VR/AR) Market in Healthcare (U.S. Markets for Surgery; Medical Education and Training; Pain Management, Rehabilitation and Therapy) Virtual Reality and Augmented Reality (VR/AR) Market in Healthcare provides market analysis and examines applications for virtual reality (VR) and augmented reality (AR) in healthcare, including the following: • the Total US Market for VR/AR in Surgery (2012/2017/2022) • the Total US Market for VR/AR in Pain Management, Rehabilitation and Therapy (2012/2017/2022) • the Total US Market for...
    Virtual Reality in Medical Education and Training (Surgical Simulation and Other VR)

    Published: November 9, 2017 | Price: $760.00 – $1,600.00

    This Kalorama Information report covers the market for virtual reality and augmented reality systems related to medical education and training.  The market for virtual reality (VR) and augmented reality (AR) products and services in medical education and healthcare training is predominately based in surgical simulators. Virtual reality and augmented reality technology has developed into a comprehensive tool in the surgical workflow – assisting training, rehearsal, and surgical performance in operating room (OR). The growing volume and variety of minimally invasive...
    Virtual Reality in U.S. Healthcare (Markets for Remote Surgery, 3D Modeling, Pain Distraction and Other Applications)

    Published: August 1, 2007 | Price: $3,995.00 – $7,990.00

    The use of virtual reality (VR) technologies in the healthcare field is not simply a far-away future possibility. Technologies are already in place and the benefits from the application of VR are already evident in the healthcare domain. These applications provide doctors an opportunity to perform tasks in a risk-free environment, and make training accessible for a large number of students as the apprenticeship of experienced doctors is not necessary. Additionally, VR simulators allow medical professionals to remain abreast with...
    Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues

    Published: September 1, 2004 | Price: $3,500.00 – $7,000.00

    With an aging population in the United States, the incidence of prevalence of age-related diseases and disorders is expected to mount rapidly over the next decade. Since senior citizens already consume a disproportionate amount of healthcare dollars, the economic picture will only go from bad to worse insofar as healthcare is concerned. The solution to this problem, for this generation and the future, is prevention. The new emphasis on prevention opens up a scope of opportunity in the alternative care...
    What is Working in IVD: Successful Commercialization of New Products and Technologies

    Published: July 1, 2009 | Price: $995.00 – $1,900.00

    As Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies The report is written by Kalorama's lead diagnostic expert, Shara Rosen, R.T. M.B.A., author of six best-selling editions of the industry's leading market research report...
    What’s Next in Biopharmaceuticals? (mAbs, rDNA, Interferons, and Other Upcoming Biologic Drugs) 2011-2015

    Published: May 1, 2011 | Price: $150.00 – $300.00

    The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead the market now and what can we expect to see in the coming years? Find out in Kalorama Information's report, What's Next in Biologics?, which represents our latest research into the market for non-vaccine biological...
    What’s Next In Vaccines (Malaria, Diabetes, Alzheimer’s, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

    Published: June 5, 2012 | Price: $3,995.00 – $7,990.00

    Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched.    What diseases may see a prophylactics vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can...
    What’s Next in Vaccines? HIV, Malaria, MRSA, and 30 Other Vaccine Targets in the 2010-2016 Pipeline

    Published: February 1, 2010 | Price: $1,500.00 – $8,400.00

    The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine...